News

Ultromics receives FDA clearance

How will artificial intelligence impact healthcare?

10 amazing European AI start-ups to watch

Ultromics founder awarded Forbes 30 Under 30 Europe Science & Healthcare

AI in cardiovascular health

Top 10 advancements in health around the world thanks to AI

Ultromics becomes founding partner of AI centre of excellence

Ultromics expands coronary artery disease trials to the U.S.

Ultromics secures additional £1m investment from Woodford Investment Management

Start-ups leveraging AI to improve outcomes and put patients in control of their care

The young biotech entrepreneurs bringing grey hair into the C-suite

Artificial intelligence will improve medical treatments

Ultromics AI platform to expand trials to 20 NHS hospitals

Ultromics secures £10 million investment to bring AI heart diagnostics to hospitals

Ultromics CEO Ross Upton was interviewed on BBC

Artificial intelligence ‘to diagnose heart disease

AI early diagnosis could save heart and cancer patients

*Pending FDA 510(k) clearance, not available for sale in the United States, not CE-marked

**CAUTION–Investigational device. Limited by Federal (or United States) law to investigational use